IKK2-IN-4
IKK2-IN-4 (compound 4) is a potent IKK-2 inhibitor, with an IC50 of 25 nM. IKK2-IN-4 can inhibit the LPS-induced production of TNFα in PBMCs[1].
Product Specifications
CAS Number
354811-10-2
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
IKK
Type
Reference compound
Related Pathways
NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ikk2-in-4.html
Purity
99.89
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=C(NC(N)=O)SC(C2=CC=CC=C2)=C1)N
Molecular Formula
C12H11N3O2S
Molecular Weight
261.30
Precautions
H302, H315, H319, H335
References & Citations
[1]Baxter A, et, al. Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors. Bioorg Med Chem Lett. 2004 Jun 7;14 (11) :2817-22.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
IKK-β
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040630-100 1x 100 µL
Mucin 1 / EMA / Episialin / CD227 (VU-2G7), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741866-500 1x 500 µL
Calponin-1 (Smooth Muscle Marker) (rCNN1/832), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC402550-100 1x 100 µL
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/2550R), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880252-500 1x 500 µL
Cytokeratin, Acidic (Type I or LMW) (Epithelial Marker) (AE-1), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 